CONSOLIDATED BALANCE SHEETS (USD $)	Oct. 31, 2014	Jul. 31, 2014	Oct. 31, 2014 Series A Convertible Preferred Stock	Jul. 31, 2014 Series A Convertible Preferred Stock	Oct. 31, 2014 Series B Convertible Preferred Stock	Jul. 31, 2014 Series B Convertible Preferred Stock	Oct. 31, 2014 Series C Convertible Preferred Stock	Jul. 31, 2014 Series C Convertible Preferred Stock	Oct. 31, 2014 Series D Convertible Preferred Stock	Jul. 31, 2014 Series D Convertible Preferred Stock	Oct. 31, 2014 Series E Convertible Preferred Stock	Jul. 31, 2014 Series E Convertible Preferred Stock
ASSETS
Cash and cash equivalents	$ 2,215,438	$ 3,269,489
Other current assets	168,526	201,314
Total Current Assets	2,383,964	3,470,803
Property and Equipment, Net	4,688	5,293
Patents, Net	1,943,054	2,046,361
TOTAL ASSETS	4,331,706	5,522,457
LIABILITIES AND STOCKHOLDERS' DEFICIENCY
Accounts payable and accrued expenses (Note 5)	7,422,094	8,034,122
Deferred revenue	223,662	223,662
Total Current Liabilities	7,645,756	8,257,784
Derivative Warrant Liability (Note 8 and 9)	2,118,177	2,635,643
Derivative Additional Investment Rights Liability (Note 8 and 9)	524,576	719,088
Total Liabilities	10,288,509	11,612,515
Stockholders' Deficiency (Notes 8):
9% Convertible Preferred Stock
Common stock, $.001 par value; authorized 1,500,000,000 shares at October 31, 2014 and July 31, 2014, respectively; 789,848,649 and 778,512,092 issued and outstanding at October 31, 2014 and July 31, 2014, respectively	789,848	778,512
Additional paid-in capital	362,376,456	362,307,678
Accumulated deficit	(369,898,699)	(369,948,322)
Accumulated other comprehensive income	775,592	772,074
Total Stockholders' Deficiency	(5,956,803)	(6,090,058)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	$ 4,331,706	$ 5,522,457